Molecular subtypes of ischemic heart disease based on circadian rhythm

[1]  Fuqi Wang,et al.  An assessment system for clinical and biological interpretability in ulcerative colitis , 2024, Aging.

[2]  Xuena Li,et al.  Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases , 2023, Journal of clinical medicine.

[3]  Xiaohui Cui,et al.  Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability , 2023, iScience.

[4]  J. Li,et al.  Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer. , 2023, Cellular signalling.

[5]  V. Swarup,et al.  hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data , 2023, Cell reports methods.

[6]  Zhen Qin,et al.  Differential expression profiles of plasma exosomal microRNAs in dilated cardiomyopathy with chronic heart failure , 2023, Journal of cellular and molecular medicine.

[7]  Xiaohui Cui,et al.  Three-dimensional bioprinting of artificial blood vessel: Process, bioinks, and challenges , 2023, International journal of bioprinting.

[8]  Xiaohui Cui,et al.  Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. , 2023, European journal of pharmacology.

[9]  Tao-Sheng Li,et al.  Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes , 2022, Journal of Translational Medicine.

[10]  J. Hanchard,et al.  Disrupting circadian control of peripheral myogenic reactivity mitigates cardiac injury following myocardial infarction , 2022, Cardiovascular research.

[11]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[12]  Amber N. Habowski,et al.  Disruption of the circadian clock drives Apc loss of heterozygosity to accelerate colorectal cancer , 2022, Science advances.

[13]  Xiaohui Cui,et al.  Uncovering the genetic links of SARS‐CoV‐2 infections on heart failure co‐morbidity by a systems biology approach , 2022, ESC heart failure.

[14]  Zhenqiang Sun,et al.  Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer , 2022, Nature Communications.

[15]  P. Libby.  Inflammation during the life cycle of the atherosclerotic plaque. , 2021, Cardiovascular research.

[16]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[17]  Wei He,et al.  Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study , 2021, Frontiers in Oncology.

[18]  S. Martin,et al.  Coronary Heart Disease Risk: Low-Density Lipoprotein and Beyond. , 2021, Trends in cardiovascular medicine.

[19]  Yuan-Lin Guo,et al.  Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease , 2021, Hepatology International.

[20]  B. Zhang,et al.  m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer , 2020, Molecular Cancer.

[21]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[22]  Supriyo Chakraborty,et al.  A review on coronary artery disease, its risk factors, and therapeutics , 2019, Journal of cellular physiology.

[23]  D. Atar,et al.  The myth of ‘stable’ coronary artery disease , 2019, Nature Reviews Cardiology.

[24]  T. Powles,et al.  Molecular and histopathology directed therapy for advanced bladder cancer , 2019, Nature Reviews Urology.

[25]  L. V. Van Laake,et al.  Circadian rhythms and the molecular clock in cardiovascular biology and disease , 2019, Nature Reviews Cardiology.

[26]  I. Rabinovich-Nikitin,et al.  Circadian-Regulated Cell Death in Cardiovascular Diseases , 2019, Circulation.

[27]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[28]  A. Relógio,et al.  Escaping Circadian Regulation: An Emerging Hallmark of Cancer? , 2018, Cell systems.

[29]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[30]  A. Butte,et al.  xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, Genome Biology.

[31]  T. Jacks,et al.  Circadian Rhythm Disruption Promotes Lung Tumorigenesis. , 2016, Cell metabolism.

[32]  Monika S. Kowalczyk,et al.  Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cells , 2015, Genome research.

[33]  Z. Rancic,et al.  Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging , 2015, Molecules.

[34]  A Heather Eliassen,et al.  Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. , 2015, Journal of the American College of Cardiology.

[35]  G. Brainard,et al.  Breast cancer and circadian disruption from electric lighting in the modern world , 2014, CA: a cancer journal for clinicians.

[36]  Y. Momiyama,et al.  Inflammation, Atherosclerosis and Coronary Artery Disease , 2014, Clinical Medicine Insights. Cardiology.

[37]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[38]  Yujin Hoshida,et al.  Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment , 2010, PloS one.

[39]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[40]  B. Lehmann,et al.  Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2. , 2010, American journal of physiology. Heart and circulatory physiology.

[41]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[42]  Flora Peyvandi,et al.  Genetic architecture of coronary artery disease in the genome-wide era: implications for the emerging "golden dozen" loci. , 2009, Seminars in thrombosis and hemostasis.

[43]  A. Tamakoshi,et al.  A prospective cohort study of shift work and risk of ischemic heart disease in Japanese male workers. , 2006, American journal of epidemiology.

[44]  J. Muller,et al.  Circadian variation and triggering of acute coronary events. , 1999, American heart journal.

[45]  M J Davies,et al.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.

[46]  R. Virmani,et al.  Coronary Artery Calcification and its Progression: What Does it Really Mean? , 2018, JACC. Cardiovascular imaging.

[47]  M. Young.  The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. , 2006, American journal of physiology. Heart and circulatory physiology.

[48]  M. Kanehisa,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..